EUVIMEDEUVIMED entdecken
Fallbericht

Ketamine-induced sclerosing cholangitis: a case series

A Vanrusselt, J Nijs, L Van den Bergh, N Schoofs, S Smets, D Strybol, A Rappaport

Acta Gastro Enterologica Belgica · 30.09.2025 · 88 (3) · 271

DOI: 10.51821/88.3.13914 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Gastro Enterologica Belgica, online erschienen am 07.10.2025. Verfasst von A Vanrusselt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sint-Trudo Ziekenhuis, Diestersteenweg 100, 3800 Sint-Truiden, Belgium. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Ketamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ketamine-induced sclerosing cholangitis is an under-recognized but emerging condition, associated with chronic recreational ketamine use (1,2). While the bladder dysfunction related to ketamine abuse is well-documented, its hepatobiliary complications are less known (3). The disease mechanism remains unclear. It is suspected that ketamine has an effect on N-methyl-D-aspartate receptors in the bile duct smooth17:09 11/10/2025 muscle, which contributes to chronic inflammation, fibrosis, and strictures. Patients present with abnormal liver function tests, imaging abnormalities, and aberrant liver biopsy. Management requires cessation of ketamine use, symptomatic treatment and close monitoring to prevent progression to cirrhosis (4-8). Cases: This case series presents two cases of ketamine-induced sclerosing cholangitis in female patients, a demographic not typically represented in existing literature.

Conclusion

A multidisciplinary approach involving gastroenterologists, urologists, and psychiatrists is necessary (5). Long-term studies are needed to better understand the pathophysiology and to approve treatment and management of this disease.

Conclusion

A multidisciplinary approach involving gastroenterologists, urologists, and psychiatrists is necessary (5). Long-term studies are needed to better understand the pathophysiology and to approve treatment and management of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingKetamineFemaleHumans

Stichwörter der Autor:innen

Ketaminecirrhosissclerosing cholangitis

Substanzen

Ketamine

Autor:innen und Institutionen

  • Sint-Trudo Ziekenhuis, Diestersteenweg 100, 3800 Sint-Truiden, Belgium.

Zitieren

APA

Vanrusselt, A., Nijs, J., Van den Bergh, L., Schoofs, N., Smets, S., Strybol, D., & Rappaport, A. (2025). Ketamine-induced sclerosing cholangitis: a case series. Acta Gastro Enterologica Belgica, 88(3), 271. https://doi.org/10.51821/88.3.13914

Vancouver

Vanrusselt A, Nijs J, Van den Bergh L, Schoofs N, Smets S, Strybol D, et al. Ketamine-induced sclerosing cholangitis: a case series. Acta Gastro Enterologica Belgica. 2025;88(3):271. doi:10.51821/88.3.13914

BibTeX
@article{Vanrusselt2025,
  author = {Vanrusselt, A and Nijs, J and Van den Bergh, L and Schoofs, N and Smets, S and Strybol, D and Rappaport, A},
  title = {Ketamine-induced sclerosing cholangitis: a case series},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2025},
  volume = {88},
  number = {3},
  pages = {271},
  doi = {10.51821/88.3.13914}
}
Kostenlos starten →